Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers
Status:
Completed
Trial end date:
2002-06-01
Target enrollment:
Participant gender:
Summary
To evaluate azithromycin tear concentrations after instillation of one drop of one of the
three T1225 concentrations (0.5%, 1% and 1.5%) and to evaluate the ocular safety.